Mount Gibson Iron Ltd (MGX)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.315 |
|---|---|
| 52-week range | 0.305 – 0.495 |
| Return, 1 month / 3 months | −7.4% / −8.7% |
| Return, 1 year / 3 years | −33.0% / −34.4% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 50.3% |
| Worst drawdown (1 year) | -36.7% |
| Average daily value traded | 0.14M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mount Gibson Iron is an Australian iron ore miner based in Perth, Western Australia. The company produces direct shipping iron ore from its operations, most notably the Koolan Island mine off the Kimberley coast, and it has also drawn ore from deposits in the Mid West region of the state. Its customers are mainly steel mills and iron ore traders, largely in Asia, who take the ore by sea from port facilities in Western Australia.
The shares are listed on the Australian Securities Exchange in Australia under the code MGX, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mount Gibson Iron Ltd (MGX) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.315 on 19 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 736 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 33.0% and over the last three months it fell 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.6% | ||
| From 52-week high | -35.7% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.7% | ||
| 6-month return | -17.1% | ||
| 12-month return, skipping the last month | -27.7% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.7% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.14M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | −7.4% |
| 3 months | −8.7% |
| 6 months | −17.1% |
| 1 year | −33.0% |
| 3 years | −34.4% |
| 5 years | −30.0% |
Signals
| 50-day / 200-day average | 0.342 / 0.378 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.011 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2021 | AUD 0.0200 |
| 1 Sep 2020 | AUD 0.0300 |
| 3 Sep 2019 | AUD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.